Real world glucose and weight control in patients treated with GLP-1 receptor agonists, with addition or treatment change to insulin

被引：0
|
作者：
Klein, K. [1 ]
Shaunik, A. [2 ]
Paul, S. [1 ]
机构：
[1] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
[2] AstraZeneca, Washington, DC USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
798
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
    Piccini, Sara
    Favacchio, Giuseppe
    Morenghi, Emanuela
    Mazziotti, Gherardo
    Lania, Andrea G. A.
    Mirani, Marco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 212
  • [2] Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients
    Alenezi, Bandar T.
    Elfezzani, Nadra
    Uddin, Rukhsana
    Patel, Hinali
    Chester, Sydney
    Abdelmaksoud, Ahmed
    Hussein, Mohammad H.
    Zaitone, Sawsan A.
    Fawzy, Manal S.
    Aiash, Hani
    Toraih, Eman A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [3] Real-world weight change, adherence and discontinuation among type 2 diabetes patients initiating GLP-1 receptor agonists (GLP-1RAs) in the UK
    Weiss, T.
    Iglay, K.
    Carr, R.
    Mishra, A. P.
    Yang, L.
    Rajpathak, S.
    DIABETOLOGIA, 2019, 62 : S371 - S371
  • [4] THE IMPACT OF GLP-1 RECEPTOR AGONISTS ON PATIENTS WITH DIABETES ON INSULIN THERAPY
    Gyorffy, Janelle B.
    Keithler, Andrea N.
    Wardian, Jana L.
    Zarzabal, Lee A.
    Rittel, Alexander
    True, Mark W.
    ENDOCRINE PRACTICE, 2019, 25 (09) : 935 - 942
  • [5] Diabetic ketoacidosis with GLP-1 receptor agonists, insulin
    Reactions Weekly, 2019, 1760 (1) : 1 - 1
  • [6] GLP-1 receptor agonists in the treatment of obesity
    Disse, E.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2024, 28 (01): : 18 - 21
  • [7] Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas
    JOURNAL OF DIABETES RESEARCH, 2023, 2023
  • [8] Combined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles?
    Yang, Tianrui
    Cutshall, B. Tate
    Tatara, Alexandra
    Ruegger, Melanie
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (04) : 447 - 449
  • [9] GLP-1 agonists and insulin in obese insulin-treated patients with type 2 diabetes: combined treatment or substitution? Weight and metabolic benefits
    Bertoin, F.
    Paoli, A.
    Ancelle, D.
    Decoudier, B.
    Francois, M.
    Lukas-Croisier, C.
    Bertin, E.
    Crouzet, M.
    Moysset, P.
    Hecart, A. -C.
    Malgrange, D.
    Delemer, B.
    DIABETOLOGIA, 2012, 55 : S298 - S299
  • [10] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
12345